Company: HROW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001641172-25-000925
Chunk: 8

Company: HARROW, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1
Chunk 8
---
AZIA
     
    France
  
    NEVANAC
     
    U.S.
  
    FRESHKOTE
     
    France
  
    MAXIDEX
     
    U.S.
  
    MAXITROL
     
    Belgium
  
    IOPIDINE 1%
     
    France

 8 

Ophthalmology Market

For any ocular procedure, a surgeon
may require drugs for sedation, dilation, anesthesia, inflammation and infection prevention, and ocular surface preservation. The cataract
surgery market continues to experience significant growth. According to Market Scope, approximately 4.8 million lens procedures
were performed in the U.S. in 2021, 97% of which were cataracts, with the number expected to grow to 5.5 million lens procedures in 2026.
Nearly 96% of the refractive surgery procedures performed are LASIK (laser in situ keratomileusis) surgeries, an outpatient surgical
procedure used to treat nearsightedness, farsightedness, and astigmatism. According to an article published in 2021 in Clinical Ophthalmology,
an estimated 800,000 eyes were treated with laser correction surgery (such as LASIK) each year for the previous ten years.

Dry eye occurs when the eye does
not produce enough tears, or when the tears are not of the correct consistency and evaporate too quickly. Inflammation of the surface
of the eye may also occur. According to a 2023 Market Scope report, there are 39 million people in the U.S. that suffer from both
signs and symptoms of dry eye, with 49% of diagnosed dry eye patients having moderate to severe dry eye. The same report stated the global
dry eye product market is expected to grow from $5.8 billion in 2023 to $7.5 billion in 2028. Dry eye is among the most common conditions
seen by eyecare professionals.

Intravitreal
injections are one of the most common procedures performed by ophthalmologists in the U.S. According to a 2023 article published in
Healio, approximately 8 million intravitreal injections were expected to be performed that year. These injections are utilized
to administer critical medications into the eye that treat diseases including but not limited to proliferative diabetic retinopathy,
diabetic macular edema, wet age-related macular degeneration, neovascular